Prothena Corp PLC (PRTA)
49.11
+0.99 (+2.06%)
USD |
NASDAQ |
Mar 29, 13:00
Prothena Cash from Investing (TTM): -0.464M for Dec. 31, 2022
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -0.464M |
September 30, 2022 | -0.632M |
June 30, 2022 | -0.71M |
March 31, 2022 | -0.549M |
December 31, 2021 | -0.575M |
September 30, 2021 | -0.307M |
June 30, 2021 | -0.176M |
March 31, 2021 | -0.222M |
December 31, 2020 | -0.196M |
September 30, 2020 | -0.251M |
June 30, 2020 | -0.423M |
March 31, 2020 | -0.446M |
December 31, 2019 | -0.547M |
September 30, 2019 | -1.738M |
June 30, 2019 | -1.641M |
March 31, 2019 | -1.671M |
December 31, 2018 | -1.729M |
September 30, 2018 | -0.808M |
June 30, 2018 | -1.194M |
March 31, 2018 | -1.303M |
December 31, 2017 | -3.521M |
Date | Value |
---|---|
September 30, 2017 | -10.29M |
June 30, 2017 | -18.31M |
March 31, 2017 | -18.80M |
December 31, 2016 | -16.64M |
September 30, 2016 | -10.48M |
June 30, 2016 | -2.256M |
March 31, 2016 | -1.592M |
December 31, 2015 | -1.382M |
September 30, 2015 | -0.437M |
June 30, 2015 | -0.214M |
March 31, 2015 | -0.501M |
December 31, 2014 | -0.499M |
September 30, 2014 | -0.456M |
June 30, 2014 | -0.577M |
March 31, 2014 | -0.451M |
December 31, 2013 | -0.535M |
September 30, 2013 | -1.565M |
June 30, 2013 | -1.441M |
March 31, 2013 | -1.274M |
December 31, 2012 | -1.301M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.738M
Minimum
Sep 2019
-0.176M
Maximum
Jun 2021
-0.7791M
Average
-0.562M
Median
Cash from Investing (TTM) Benchmarks
Mallinckrodt PLC | -- |
Jazz Pharmaceuticals PLC | -446.23M |
Nabriva Therapeutics PLC | -0.268M |
Iterum Therapeutics PLC | 13.96M |
GH Research PLC | -84.69M |